RegisterLogin

Research Grade Risankizumab

CAT: 1358-HV466016-01Size: 100 µgDry Ice: NoHazardous: No
CAT#:1358-HV466016-01Size:100 µg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Product Name Alternative
BI655066, risankizumab-rzaa, CAS:1612838-76-2
Expression System
Mammalian Cells
Host
Humanized
Target
SGRF, IL-23-A, IL-23subunitalpha, Interleukin-23subunitp19, IL23A, Interleukin-23subunitalpha, IL-23p19
Clonality
Monoclonal
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Purification
Protein A/G purified from cell culture supernatant.
Concentration
5.1mg/ml
Endotoxin
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Form
Liquid
Buffer
0.01M PBS, pH7.4.
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at4°C short term (1-2weeks) . Store at-20°C 12 months. Store at -719°C long term.
Notes
For research use only. Not suitable for clinical or therapeutic use.
Buffer pH
0.01M PBS, pH7.4.
Species
Human
Isotype
IgG1-kappa

Related Products

CatalogName
HV571026-01Research Grade Enoticumab
HV571036-01Research Grade Navicixizumab
HV571046-01Research Grade Dilpacimab
HB825026-01Research Grade Mirvetuximab
HV185036-01Research Grade Setrusumab
HC496026-01Research Grade Amatuximab
HX246016-01Research Grade Ensituximab
HB816016-01Research Grade Imalumab
HF574026-01Research Grade Upifitamab
HT020016-01Research Grade Narsoplimab

Alternative Products

CatalogName
MBS1563932-01Research Grade Risankizumab
ICH5210-20mgRisankizumab Biosimilar - Research Grade
10-735Risankizumab (IL23A) - Research Grade Biosimilar
GC0059Research Grade
MBS3030366-01Camrelizumab - Research Grade
DHE54301Research Grade Asunercept
DHF19801Research Grade Zolbetuximab
DHD14201Research Grade Gatipotuzumab
DHC21301Research Grade Lumiliximab
DHA30301Research Grade Denosumab

Popular Products